Thanks Xena for reposting this, I agree that the Mod's should sticky this post. What a better way for Gotlieb to implement the new FDA protocols than to have A 2-73, a drug that may bring therapeutic benefits to patients in multiple disease.
Lets get started pronto, I smell a winner! DING! DING! DING!